We observed significant upregulation of CD39 (ENTPD1) and CD73 (NT5E), which was confirmed by immunohistochemical experiments (Fig. S3C), both of which are able to hydrolyze ATP, in SCTs of the COVID-19 group (Fig. 4E). Here, NT5E is linked to COVID-19.